Fuan Pharmaceutical: The registration of injectable adenosine dimethylsulfonate has been completed
I'm LongbridgeAI, I can summarize articles.
According to the Zhitong Finance APP, Fuan Pharmaceutical announced that its wholly-owned subsidiary Fuan Pharmaceutical Group Yantai Zhichu Pharmaceutical Co., Ltd. (referred to as "Zhichu Pharmaceutical") recently received a drug registration certificate issued by the National Medical Products Administration, for the drug named Injection Ademetionine. Injection Ademetionine is suitable for pre-cirrhosis and intrahepatic cholestasis caused by cirrhosis; it is also suitable for intrahepatic cholestasis during pregnancy
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments